2012 Series - Free Webinar April 25th!
Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, Noon–1:05 p.m.Presentation Topics:
- Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial
Presenter: Jonathan P. Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC
View abstract | Science News Summary
- Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery
Presenter: Ronald B. Easley, Baylor Coll of Med, Houston, TX
View manuscript | Science News Summary
Leave a Comment
Log in to post a comment.